SEC 13F Intelligence

Candriam S.c.a. / MRK

Candriam S.c.a.’s Merck & Co Inc Position

Does Candriam S.c.a. own Merck & Co Inc (MRK)? Yes — 1.28M shares worth $134M (+0.67% of its 13F portfolio) as of Q1 2026, down from 1.28M shares the prior filed quarter.

Position Value
$134M
Q1 2026
Shares
1.28M
% of Portfolio
+0.67%
Quarters Held
30
currently held

Position History MRK

Reported value by quarter
Q4 ’18: $76MQ4 ’18Q1 ’19: $130MQ2 ’19: $141MQ3 ’19: $133,000Q4 ’19: $127MQ4 ’19Q1 ’20: $124MQ2 ’20: $158MQ3 ’20: $243MQ4 ’20: $299MQ4 ’20Q1 ’21: $287MQ2 ’21: $336MQ3 ’21: $275MQ4 ’21: $203MQ4 ’21Q1 ’22: $290MQ2 ’22: $317MQ3 ’22: $300MQ4 ’22: $356MQ4 ’22Q1 ’23: $340MQ2 ’23: $361MQ3 ’23: $343MQ4 ’23: $330MQ4 ’23Q1 ’24: $326MQ2 ’24: $295MQ3 ’24: $280MQ4 ’24: $221MQ4 ’24Q1 ’25: $193MQ2 ’25: $131MQ3 ’25: $119MQ4 ’25: $134MQ4 ’25Q1 ’26: $134Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.28M$134M+0.67%
Q4 20251.28M$134M+0.67%
Q3 20251.42M$119M+0.62%
Q2 20251.65M$131M+0.76%
Q1 20252.15M$193M+1.21%
Q4 20242.22M$221M+1.27%
Q3 20242.47M$280M+1.61%
Q2 20242.38M$295M+1.79%
Q1 20242.47M$326M+2.09%
Q4 20233.03M$330M+2.28%
Q3 20233.34M$343M+2.43%
Q2 20233.13M$361M+2.61%
Q1 20233.47M$340M+2.36%
Q4 20223.21M$356M+2.40%
Q3 20223.48M$300M+2.11%
Q2 20223.48M$317M+2.61%
Q1 20223.54M$290M+1.98%
Q4 20212.65M$203M+1.30%
Q3 20213.66M$275M+1.87%
Q2 20214.32M$336M+2.30%
Q1 20213.66M$287M+2.39%
Q4 20203.66M$299M+2.37%
Q3 20202.93M$243M+2.29%
Q2 20202.04M$158M+1.66%
Q1 20201.39M$124M+1.37%
Q4 20191.39M$127M+1.36%
Q3 20191.57M$133,000+1.67%
Q2 20191.68M$141M+1.76%
Q1 20191.56M$130M+1.67%
Q4 20181.00M$76M+1.17%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Candriam S.c.a.’s full portfolio or all institutional holders of MRK.